Publikationen in Zusammenarbeit mit Forschern von VU University Amsterdam (22)

2024

  1. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

    Biological Psychiatry

2023

  1. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  2. Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis

    European Psychiatry, Vol. 66, Núm. 1

  3. Linking heart rate variability to psychological health and brain structure in adolescents with and without conduct disorder

    Frontiers in Psychiatry, Vol. 14

  4. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  5. Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome

    Schizophrenia bulletin, Vol. 49, Núm. 2, pp. 339-349

2022

  1. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

    Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842

  2. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

  3. Organisational implementation climate in implementing internet-based cognitive behaviour therapy for depression

    BMC Health Services Research, Vol. 22, Núm. 1

  4. The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population

    Annals of Internal Medicine, Vol. 175, Núm. 11, pp. 1560-1571

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  2. Corrigendum to “Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121–136]” (European Neuropsychopharmacology (2020) 36 (121–136), (S0924977X20301802), (10.1016/j.euroneuro.2020.05.006))

    European Neuropsychopharmacology

  3. DNA methylation signatures of aggression and closely related constructs: A meta-analysis of epigenome-wide studies across the lifespan

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2148-2162

  4. DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network

    European Neuropsychopharmacology, Vol. 47, pp. 54-61

2020

  1. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

    Acta Neuropathologica

  2. Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis

    Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 823-833

  3. Neuropsychological Subgroups of Emotion Processing in Youths With Conduct Disorder

    Frontiers in Psychiatry, Vol. 11

  4. Psychophysiological responses to sadness in girls and boys with conduct disorder.

    Journal of Abnormal Psychology

2019

  1. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

    Acta Neuropathologica, Vol. 138, Núm. 2, pp. 237-250

  2. Baseline autonomic nervous system activity in female children and adolescents with conduct disorder: Psychophysiological findings from the FemNAT-CD study

    Journal of Criminal Justice, Vol. 65